Kuecept set for Japanese Trade Mission


Specialist pharmaceutical research and development organisation Kuecept Ltd is one of only 14 firms across the UK that is attending the week-long UK Trade & Investment (UKTI) Bio and Pharma trade mission to Japan in Febraury 2012.

Dr Ashvin Patel, Development Manager at Kuecept  will be representing the company and will present to delegates at the British Embassy in Tokyo (1.30 p.m, Thursday 17th Feb) and an additional seminar in Osaka (Osaka Hilton Hotel, 2 p.m, Monday 13th Feb).

With the assistance of the UKTI team in Japan, both Dr Patel and Kuecept's Chief Executive Officer, Bryn Williams,will meet several Japanese firms with a view to generating interest in the company's specialist contract formulation research and development services and drug delivery technologies.

About UK Trade & Investment (UKTI) 

UK Trade & Investment (UKTI) is the Government department that helps UK-based companies succeed in the global economy. We also help overseas companies bring their high quality investment to the UK’s economy – acknowledged as Europe’s best place from which to succeed in global business.

UKTI offers expertise and contacts through its extensive network of specialists in the UK, and in British embassies and other diplomatic offices around the world. We provide companies with the tools they require to be competitive on the world stage. For more information on UKTI, visit www.ukti.gov.uk or telephone +44 (0)20 7215 8000. 

20 January 2012